Regeneron Pharmaceuticals | DETTE



Debt Changement Date
AbbVie USD 67.14B 3.94B 2024-12
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 57.38B 2.72B 2025-03
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
J&J USD 52.25B 15.62B 2025-03
Kyowa Hakko Kirin JPY 0 28.75B 2025-03
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 17.91B 5.85B 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Teva Pharmaceutical Industries USD 18.08B 901M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Regeneron Pharmaceuticals DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.